CClinicalTrials.gg
CompletedNCT01597011Updated Mar 18, 2015

Long-term Follow-up After Laparoscopic Inguinal Hernia Repair Using Tisseel for Mesh Fixation

An observational study in Hernia, Inguinal, Recurrence and Chronic Pain, sponsored by Herlev Hospital. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-03-18.

Sponsored by Herlev Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
2,340
Ages
18 Years and older
Sex
All
01

Study summary

In hernia repair a mesh is used to close the defect in the abdominal wall. This mesh is either secured with tissue penetrating devices (ex. staples,tacks or sutures) or fibrin glue (Tisseel/Tissucol) or left unfixated.

The investigators believe, and previous studies indicate, that the use of fibrin glue greatly reduces the amount of postoperative complications (ex. chronic pain, impaired ejaculation in men or recurrence of the hernia)when compared with the use of tacks or staples.

The aim of this study is to compare the recurrence rates and amount of postoperative complications in patients who have had inguinal hernia repair with fibrin glue and in patients who have had inguinal hernia repair with tacks, staples or sutures.

Read the detailed description

The study will use prospectively collected data from the Danish Hernia Database to find the patients. The patients will be contacted using a questionnaire.

02

Conditions studied

  • Hernia, Inguinal
  • Recurrence
  • Chronic Pain

Keywords

  • Hernia, Inguinal
  • Hernia repair
  • Fibrin Tissue Adhesive
  • Tisseel
  • Tissucol
  • Recurrence
  • Chronic Pain
  • Dysejaculation
03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.

This study's enrollment of 2,340 is above the median of 126 across 688 observational studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Herlev Hospital is the lead sponsor of 195 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients will be enrolled based on their registration in the Danish Hernia Database. All patients in the database who have undergone laparoscopic inguinal hernia repair from January 2009 to September 2012 will be included.

Inclusion criteria

inguinal hernia repair from January 2009-September 2012

Exclusion criteria

Exclusion Criteria:

Patients lost to follow-up

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
2,340 participants (actual)

Groups and cohorts

  • Fibrin sealant group

    Patients who have undergone laparoscopic inguinal hernia repair with fibrin sealant for mesh fixation

    Procedure: Fibrin Sealant

  • Tissue-penetrating fixation group

    Patients who have undergone laparoscopic inguinal hernia repair with the use of tacks, staples or sutures for mesh fixation

    Procedure: Tissue-penetrating mesh-fixation

Interventions

  • ProcedureFibrin Sealant

    Use of fibrin sealant for mesh fixation in laparoscopic inguinal hernia repair,

    Also known as: Tisseel, Fibrin glue

  • ProcedureTissue-penetrating mesh-fixation

    Use of tacks, staples or sutures for mesh fixation in inguinal hernia repair

    Also known as: Protacks, Hernia stapler

06

What researchers measure

Primary outcomes

  1. Chronic pain

    Reported pain (questionnaire) from one year after procedure

    Time frame: within period from one year after procedure until follow-up

Secondary outcomes

  1. Recurrence

    Reherniation at repaired site. Defined as a clinically observable hernia or reoperation prior to follow-up

    Time frame: within period from procedure to follow-up

  2. dysejaculation

    Reported ejaculatory dysfunction in male patients

    Time frame: Debut within period from procedure to follow-up

07

Study locations

1 site
  • Herlev Hospital
    Herlev, 2730, Denmark
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01597011
Lead sponsor
Herlev Hospital
Responsible party
Andreas Qwist Fenger (BSc.Med., Herlev Hospital) — Principal investigator
First posted
May 11, 2012
Start date
Jul 2012
Primary completion
Sep 2014
Completion
Sep 2014
Last update
Mar 18, 2015

Study contacts

Neel M Helvind, Researcher
principal investigator · Herlev Hospital
Jacob Rosenberg, professor
study chair · Herlev Hospital
Andreas Q Fenger, Researcher
principal investigator · Herlev Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion